Subscribe to magazine
Subscribe to newsletters
Recent from Imaging
GE Announces First U.S. Install of General Purpose Digital SPECT/CT
Global Contrast Media Injectors Market to Reach $1.8 Billion by 2022
Computed Tomography (CT)
Magnetic Resonance Imaging (MRI)
Recent from Cath Lab
Positive Twelve-Month TOBA-BTK Results Presented at SCAI 2016
SCAI Publishes Updated Cath Lab Best Practices Guidelines
Intravascular imaging systems
Peripheral Artery Disease
Recent from EP Lab
Acutus Medical Receives CE Mark for AcQMap 3-D Imaging and Mapping System
Biotronik Announces FDA Approval of MR Conditional CRT-Ds
Implantable cardioverter defibrillators (ICD)
Cardiac resynchronization therapy devices (CRT)
Leads, implantable devices
Recent from Structural Heart
First Central Pennsylvania Patients Receive New Aortic Valve Reconstruction Procedures
AtriCure Receives FDA Clearance for New AtriClip Device
Heart Valve Repair
Left atrial appendage (LAA) occluders
Structural heart occluders/closure devices
Recent from Information Diagnostics
New Case Series Examines CardioMEMS in Single Ventricle Fontan Anatomy
Heart Monitoring Suggested for All Breast Cancer Patients Undergoing Herceptin Treatment
Recent from Information Technology
SCAI Eye Exams for Interventional Cardiologists Helps Track Radiation Exposure
FTC Creates Compliance Tool for Mobile Health App Developers
Clinical decision support
Regado Biosciences Inc.
120 Mountain View Boulevard
March 25, 2015
Novel Anti-Clotting Therapy in Halted Trial No Better Than Existing Agents
A novel therapy that would allow doctors to turn the body’s blood clotting ability off and on in a more controlled way...
July 30, 2014
REGULATE-PCI Trial Testing Anticoagulant Pegnivacogin Anticoagulant Halted
July 30, 2014 — Regado Biosciences announced earlier this month it has voluntarily paused enrollment in its REGULATE-...
April 07, 2011
New Anticoagulation Agent Shows Positive Results in Clinical Trial
April 7, 2011 – Primary results from the RADAR Phase 2b clinical trial were announced at the American College of...
April 01, 2011
Clinical Trial Results for Anticoagulation System to be Presented at ACC
April 1, 2011 –Results from the RADAR Phase 2b clinical trial will be announced at the i2 Summit during the American...
September 10, 2009
RADAR Phase 2b Study Examines REG1 Anticoagulant in ACS Patients
September 10, 2009 – Regado Biosciences said this week it enrolled the first patient in a phase 2b, randomized,...
Scranton Gillette Communications
. All Rights Reserved.